Tapered dose versus constant drug exposure to anti-EGFR drugs on head-and-neck cancer xenografts. A comparison between cetuximab and gefitinib.

Abstract:

:Head-and-neck (H&N) tumor re-growth is clinically observed after arrest of anti-EGFR therapies. In the present study, we compared, for a similar dose exposure to anti-EGFR therapies, constant (CS) with tapered (TS) schedules (i.e. progressive dose reduction) for cetuximab, a mAb, and gefitinib, a TKI. Mice bearing CAL33 H&N tumors with high EGFR content were treated with cetuximab or gefitinib. CS consisted of 7 days of cetuximab or gefitinib administration and TS of 7 days of drugs followed by 7 days of administration at decreased doses (divided by 2 every day). Gefitinib TS but not CS slowed down tumor re-growth. Cetuximab TS had a stronger and longer-lasting effect than CS, paralleled by a down-regulation of EGFR expression. Whatever the drug, TS decreased tumor re-growth more efficiently than CS. This new drug schedule could be of interest in the management of anti-EGFR based therapies in H&N cancer.

journal_name

Oral Oncol

journal_title

Oral oncology

authors

Bozec A,Formento P,Fischel JL,Etienne-Grimaldi MC,Milano G

doi

10.1016/j.oraloncology.2009.11.010

subject

Has Abstract

pub_date

2010-03-01 00:00:00

pages

172-7

issue

3

eissn

1368-8375

issn

1879-0593

pii

S1368-8375(09)00979-8

journal_volume

46

pub_type

杂志文章
  • Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.

    abstract:OBJECTIVES:To establish the concept that the antigenicity/immunogenicity of ALDH(high) human head and neck squamous cell carcinoma (HNSCC) cancer stem cells (CSC) is distinct from that of ALDH(low) non-CSCs. METHODS:We generated CSC-loaded dendritic cells (DCs) to sensitize autologous peripheral blood T, B lymphocytes...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2016.05.013

    authors: Prince MEP,Zhou L,Moyer JS,Tao H,Lu L,Owen J,Etigen M,Zheng F,Chang AE,Xia J,Wolf G,Wicha MS,Huang S,Ren X,Li Q

    更新日期:2016-08-01 00:00:00

  • Staging and prognosis in head and neck cancer.

    abstract::Head and neck malignant tumors are classified according to the TNM staging system. The TNM system is a universally accepted, widely used, staging method. Its goals are to help clinicians and researchers to choose from treatment options, to give patients an estimate of their prognosis and to compare results of treatmen...

    journal_title:Oral oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.oraloncology.2008.05.022

    authors: van der Schroeff MP,Baatenburg de Jong RJ

    更新日期:2009-04-01 00:00:00

  • Transoral tongue base mucosectomy for the identification of the primary site in the work-up of cancers of unknown origin: Systematic review and meta-analysis.

    abstract:BACKGROUND:The use of transoral robotic surgery (TORS) and laser microsurgery (TLM) in the diagnosis and identification of the site of the unknown primary has become increasingly common. This systematic review and meta-analysis aims to assess the use and efficacy of TORS and TLM for this indication. METHOD:Systematic ...

    journal_title:Oral oncology

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.oraloncology.2019.02.018

    authors: Farooq S,Khandavilli S,Dretzke J,Moore D,Nankivell PC,Sharma N,Almeida JR,Winter SC,Simon C,Paleri V,De M,Siddiq S,Holsinger C,Ferris RL,Mehanna H

    更新日期:2019-04-01 00:00:00

  • Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma.

    abstract::In this study, we focused on p53 mutations in specific regions, including DNA-binding surface regions, to clarify the correlation between mutations within the specific regions of p53 and clinical outcomes of patients with oral cancers. We analyzed p53 mutations in 121 fresh primary oral squamous cell carcinomas (SCCs)...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/s1368-8375(02)00064-7

    authors: Yamazaki Y,Chiba I,Hirai A,Sugiura C,Notani K,Kashiwazaki H,Tei K,Totsuka Y,Fukuda H

    更新日期:2003-02-01 00:00:00

  • Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing.

    abstract::The recently identified single nucleotide polymorphism in the MDM2 promoter (SNP 309) may contribute to the early onset of both sporadic and hereditary malignancies in patients with defective p53. We tested this hypothesis by examining the effects of combined MDM2 polymorphisms and somatic p53 mutations on 351 oral sq...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2008.03.006

    authors: Huang SF,Chen IH,Liao CT,Wang HM,Liou SH,Hsieh LL

    更新日期:2009-01-01 00:00:00

  • Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions.

    abstract:OBJECTIVES:Cancer immunoediting represents a relatively novel concept attempting to explain the process of tumor escape from the host immune system response. Here, we attempted to elucidate the role of programmed death ligand 1 (PD-L1), the tumor microenvironment, and tumor escape mechanisms that allow malignant transf...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2017.03.006

    authors: Yagyuu T,Hatakeyama K,Imada M,Kurihara M,Matsusue Y,Yamamoto K,Obayashi C,Kirita T

    更新日期:2017-05-01 00:00:00

  • Treatment and outcomes of nasopharyngeal carcinoma in a unique non-endemic population.

    abstract:OBJECTIVE:Nasopharyngeal carcinoma (NPC) is common in Southeast Asia. Due to the influx of immigrants from this region, the incidence in British Columbia is increasing. Current literature from non-endemic populations encompasses heterogeneous cohorts. This study examines NPC in a North American population, with a high ...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2021.105182

    authors: Howlett J,Hamilton S,Ye A,Jewett D,Riou-Green B,Prisman E,Thamboo A

    更新日期:2021-01-24 00:00:00

  • Tubulopapillary hidradenoma-like tumor of the mandible: Two case reports of an underrecognized entity.

    abstract::Tubulopapillary hidradenoma-like tumor of the mandible is extremely rare, with only 3 cases published in the English-language literature. The clinicopathological characteristics and histogenesis of this tumor are unclear. Few pathologists and perhaps fewer clinicians are familiar with this entity, and it is likely und...

    journal_title:Oral oncology

    pub_type: 信件

    doi:10.1016/j.oraloncology.2019.104448

    authors: Zeng M,Guo X,Chen X,Yang S

    更新日期:2020-01-01 00:00:00

  • Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review.

    abstract::Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) generates microvascular parameters from the tracer kinetic analysis of a series of MRI images obtained in under 15 min. DCE-MRI parameters are associated with tumour hypoxia, which is well-established as a cause of treatment failure in head and neck squamo...

    journal_title:Oral oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.oraloncology.2014.07.011

    authors: Bernstein JM,Homer JJ,West CM

    更新日期:2014-10-01 00:00:00

  • Re-irradiation for recurrent and second primary cancers of the head and neck.

    abstract:PURPOSE:To evaluate a single-institutional experience with the use of re-irradiation for recurrent and new primary cancers of the head and neck. METHODS:The medical charts of 80 consecutive patients who underwent re-irradiation for local-regionally recurrent or second primary head and neck cancer between November 1998...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2017.01.007

    authors: Velez MA,Veruttipong D,Wang PC,Chin R,Beron P,Abemayor E,St John M,Chen AM

    更新日期:2017-04-01 00:00:00

  • Efficacy of super-selective neck dissection following chemoradiation for advanced head and neck cancer.

    abstract:BACKGROUND:Hypothesizing that neck-level specific locations of residual lymph node metastases following chemoradiation for head and neck cancer are highly predictable, the efficacy of the more targeted lymphadenectomy procedure called super-selective neck dissection (SSND) was evaluated. METHODS:A retrospective analys...

    journal_title:Oral oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.oraloncology.2012.05.025

    authors: Robbins KT,Dhiwakar M,Vieira F,Rao K,Malone J

    更新日期:2012-11-01 00:00:00

  • A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence.

    abstract:OBJECTIVES:Perineural invasion (PNI) is a common histopathological finding in head and neck squamous cell carcinoma (HNSCC). We aimed to explore the molecular mechanisms involved in PNI and the role of PNI as an aggressive pathological feature. MATERIALS AND METHODS:We used data from The Cancer Genome Atlas (TCGA) to ...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2018.09.005

    authors: Saidak Z,Clatot F,Chatelain D,Galmiche A

    更新日期:2018-11-01 00:00:00

  • Periodontitis and oral Cancer-A striking link.

    abstract::Oral squamous cell carcinoma (OSCC) has become a major public health problem in the worldwide for its increasing incidence and mortality, especially in younger trends. Risk factors for OSCC apart from alcohol and tobacco use, include poor oral hygiene, inflammation caused by inadequately fitting dentures and other rou...

    journal_title:Oral oncology

    pub_type: 信件

    doi:10.1016/j.oraloncology.2020.104630

    authors: Karmakar S,Kar A,Thakur S,Rao VUS

    更新日期:2020-07-01 00:00:00

  • Effects of metformin on head and neck cancer: a systematic review.

    abstract::Conventional therapeutic approaches for head and neck squamous cell carcinoma (HNSCC) are associated with many adverse effects that reduce quality of life. Therefore, identification of new less cytotoxic treatments is highly important. Metformin, which is commonly used for type 2 diabetes, may reduce cancer risk. A fe...

    journal_title:Oral oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.oraloncology.2015.01.007

    authors: Rêgo DF,Pavan LM,Elias ST,De Luca Canto G,Guerra EN

    更新日期:2015-05-01 00:00:00

  • Effects of smoking cessation on the risk of laryngeal cancer: an overview of published studies.

    abstract::Epidemiological studies showed that stopping smoking substantially decreases the risk of lung cancer. With reference to laryngeal cancer, at least four cohort studies and 15 case-control studies reported information on smoking cessation. These studies indicated that the risk of laryngeal cancer is considerably reduced...

    journal_title:Oral oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.oraloncology.2006.02.008

    authors: Bosetti C,Garavello W,Gallus S,La Vecchia C

    更新日期:2006-10-01 00:00:00

  • Intensity-modulated radiotherapy improves outcomes in postoperative patients with squamous cell carcinoma of the oral cavity.

    abstract:OBJECTIVES:We compared the outcomes and survival rates of patients with oral cavity squamous cell carcinoma receiving postoperative conventional radiotherapy (RT) or intensity-modulated radiotherapy (IMRT). MATERIALS AND METHODS:From January 2005 to September 2008, medical records of 131 consecutive patients with oral...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2012.02.010

    authors: Chen PY,Chen HH,Hsiao JR,Yang MW,Hsueh WT,Tasi ST,Lin FC,Wu YH

    更新日期:2012-08-01 00:00:00

  • Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft.

    abstract::The aim of this study was to define the appropriate fractionation interval between photodynamic therapies (PDTs) for enhanced anti-tumour effects on human oral squamous cell carcinoma (HOSCC). Reoxygenation of HOSCC and the proliferative kinetics of the tumour cells following PDT exposure were evaluated in terms of im...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2005.10.006

    authors: Togashi H,Uehara M,Ikeda H,Inokuchi T

    更新日期:2006-05-01 00:00:00

  • Topical agents for oral cancer chemoprevention: A systematic review of the literature.

    abstract:OBJECTIVES/HYPOTHESIS:We review the use of topical chemoprevention agents in patients with oral potentially malignant disorders (PMD). METHODS:A systematic review of studies on topical chemoprevention agents for oral PMD from 1946 to November 2016 was conducted using the MEDLINE database, Embase, and Cochrane Library....

    journal_title:Oral oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.oraloncology.2017.02.014

    authors: Chau L,Jabara JT,Lai W,Svider PF,Warner BM,Lin HS,Raza SN,Fribley AM

    更新日期:2017-04-01 00:00:00

  • The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.

    abstract::The aims of this study were to assess a cohort of patients with head and neck squamous cell carcinoma (HNSCC) for: (1) the prevalence of synchronous distant metastases (DM) as detected by the initial staging by using (18)F-FDG PET/CT, (2) the prevalence of metachronous DM, and (3) the validity of published risk factor...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2011.05.011

    authors: Haerle SK,Schmid DT,Ahmad N,Hany TF,Stoeckli SJ

    更新日期:2011-07-01 00:00:00

  • Inhibition of experimental tobacco carcinogen induced head and neck carcinogenesis.

    abstract::Oral cancer models have attempted to demonstrate inhibition of oral carcinogenesis. These models used synthetic carcinogens, lacked a specific mechanism of activity or used non-physiologic doses for carcinogen or inhibitor. To correct these problems the tobacco and environmental carcinogen, dibenzo[a,l]pyrene (DB[a,l]...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2003.12.012

    authors: Schwartz J,Baker V,Larios E,Desai D,Amin S

    更新日期:2004-07-01 00:00:00

  • Familial aggregation of nasopharyngeal carcinoma in Taiwan.

    abstract:BACKGROUND:The incidence of nasopharyngeal carcinoma (NPC) is higher in Chinese than in Caucasian populations. Genetic, viral, and lifestyle factors may explain these ethnic differences in the incidence of NPC. In the present study, we examined the familial aggregation, heritability, and relative risks (RRs) of NPC usi...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2017.07.020

    authors: Huang SF,Hsiao JH,Young CK,Chien HT,Kuo CF,See LC,Luo SF,Huang LH,Liao CT,Chang TJ

    更新日期:2017-10-01 00:00:00

  • Cellular factors may enable squamous carcinoma cells to overcome TGF beta-mediated repression of CDK2 activity.

    abstract::Cell lines developed from head and neck squamous cell carcinomas exhibit variable responses to the negative regulatory effects of transforming growth factor beta (TGF beta) on cell growth. To analyse the effects of TGF beta on regulators of cell cycle progression, we characterised cell lines derived from head and neck...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/s1368-8375(97)00023-7

    authors: Lesaca EE,Ensley JF,Yeudall WA

    更新日期:1998-01-01 00:00:00

  • Sebaceous adenoma of the cheek.

    abstract::Sebaceous adenoma is a tumour only rarely located in the oral cavity. Less than 10 cases have been reported. Sebaceous adenoma represents 0.5-0.7% of all monomorphic adenomas. Sebaceous adenoma is mainly constituted by two types of cells, undifferentiated peripheral basaloid cells and cells showing different degrees o...

    journal_title:Oral oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1368-8375(01)00024-0

    authors: Iezzi G,Rubini C,Fioroni M,Piattelli A

    更新日期:2002-01-01 00:00:00

  • Impact of p16-overexpression on overall and progression-free survival outcomes in oral cavity squamous cell carcinomas: A semi-national, population-based study.

    abstract:OBJECTIVES:Human papillomavirus infection and p16-overexpression is a principal cause and favorable prognostic factor for oropharyngeal squamous cell carcinomas but the value as prognostic marker in oral cavity squamous cell carcinomas (OSCC) is undetermined. MATERIALS AND METHODS:All patients diagnosed with OSCC in E...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2020.105031

    authors: Schneider K,Jakobsen KK,Jensen JS,Wessel I,Christensen A,Specht L,Lelkaitis G,Mirian C,Buchwald CV,Grønhøj C

    更新日期:2020-12-01 00:00:00

  • The prognostic significance of age in oropharyngeal squamous cell carcinoma.

    abstract:OBJECTIVES:Though the effect of age has been studied in some cancer types, its prognostic significance in oropharyngeal squamous cell carcinoma (OPSCC) remains controversial. Our purpose is to determine the impact of age at diagnosis on overall survival (OS) and disease-specific survival (DSS) in patients with OPSCC. I...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2013.12.013

    authors: Ryan Camilon P,Stokes WA,Nguyen SA,Lentsch EJ

    更新日期:2014-05-01 00:00:00

  • Clinicopathological and immunohistochemical study of 39 cases of Adenomatoid Odontogenic Tumour: a multicentric study.

    abstract::Adenomatoid Odontogenic Tumour (AOT) is a relatively uncommon odontogenic lesion and few studies describing its cytokeratin profile have been reported in the English-language literature. Thirty-nine cases of AOT from three Oral Diagnosis services (Brazil, Mexico and Guatemala) were studied, considering their clinical,...

    journal_title:Oral oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.oraloncology.2005.04.008

    authors: Leon JE,Mata GM,Fregnani ER,Carlos-Bregni R,de Almeida OP,Mosqueda-Taylor A,Vargas PA

    更新日期:2005-09-01 00:00:00

  • Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience.

    abstract:OBJECTIVES:While surgery with or without adjuvant radiation therapy (RT) is the standard of care for oral cavity cancer (OCC), a select group requires nonsurgical treatment. We provide a single-institution experience using definitive chemotherapy and RT for primary OCC. MATERIALS AND METHODS:We examined 73 patients wi...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2015.04.007

    authors: Scher ED,Romesser PB,Chen C,Ho F,Wuu Y,Sherman EJ,Fury MG,Wong RJ,McBride S,Lee NY,Riaz N

    更新日期:2015-07-01 00:00:00

  • Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines.

    abstract::Toll-like receptor 4 (TLR4) plays a significant role in cancer therapy as receptors of bacteria-derived immunotherapeutic agents such as OK-432, a streptococcal immunotherapeutic agent. In addition, recent reports demonstrated that TLRs, including TLR4, are also expressed in cancer cells as well as in immunocompetent ...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/j.oraloncology.2012.02.005

    authors: Tano T,Okamoto M,Kan S,Nakashiro K,Shimodaira S,Yamashita N,Kawakami Y,Hamakawa H

    更新日期:2012-08-01 00:00:00

  • Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period.

    abstract::The distributions of 2093 patients with nasopharyngeal carcinoma (NPC), by stage, over a 12-year-period did not show any evidence of a shift towards early stages despite growing awareness of this prevalent malignancy. The IgA VCA titre was determined for 1880 of these patients. The median titre increased from 40 in st...

    journal_title:Oral oncology

    pub_type: 杂志文章

    doi:10.1016/s1368-8375(98)00063-3

    authors: Ho S,Teo P,Kwan WH,Choi P,Tjong J,Johnson PJ

    更新日期:1998-11-01 00:00:00

  • Late stage diagnosis of oral cancer: components and possible solutions.

    abstract::Stage of disease at the diagnosis of oral cancer is thought to be a significant factor in prognosis and outcome (International Agency for Research on Cancer/World Health Organization, 2014). Unfortunately, we continue to diagnose almost 2/3 of these cancers at advanced stages of disease despite the ongoing research fo...

    journal_title:Oral oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.oraloncology.2014.09.005

    authors: Güneri P,Epstein JB

    更新日期:2014-12-01 00:00:00